RE:GOOD POINT REGARDING THE "MYSTERIOUS" EXPENSEEuropac analyst has $1 price target and buy recommendation. Octagon analyst has a $2.15 price target and buy recommendation. The mysterious expense we are told and told publicly in a news release that it is not recurring. All other expenses have gone down in relation to revenue which is a huge positive. So if this trend continues on the income statement to see downtrends in expenses relative to revenue the stock especially if it gets a US valuation I think shareholders are in good shape. The company still has $0.10 per share in cash and a rapidly growing business so $0.20 seems very unrealistic anytime soon. If the above happens and the stock stays in this range I think then the company will be a buyout target.